Drug combination highly effective in children with standard-and high-risk APL

Nov 12, 2021

A clinical trial has found that the combination of all-trans retinoic acid, which is a metabolite of vitamin A, and arsenic trioxide is highly effective in children with standard- and high-risk acute promyelocytic leukemia, or APL.

Comments

Treating a deadly childhood cancer with a sideways approach

Childhood Cancer Survivors Have Higher Risk of Chronic Conditions, Early Death

A new CAR-T-cell therapy tricks cancer cells with a decoy to increase treatment efficiency in B-cell Acute Lymphoblastic Leukaemia

Experimental treatment borrowed from blood cancer shows promise for pediatric brain tumors

Classifying childhood brain cancers by immune response may improve diagnostics and treatments

Is Less More? Rethinking Salvage Therapy in Pediatric Hodgkin Lymphoma

Newborns with heart defects may face a higher risk of developing childhood cancer

New therapeutic approach shows promise for pediatric high-grade gliomas

Space-age lessons could protect childhood cancer survivors’ bone health

Suicidal ideation significantly higher among childhood cancer survivors

Recent Posts